切换至 "中华医学电子期刊资源库"

中华肥胖与代谢病电子杂志 ›› 2016, Vol. 02 ›› Issue (04) : 237 -240. doi: 10.3877/cma.j.issn.2095-9605.2016.04.011

所属专题: 文献

综述

小肠旷置长度对胃旁路术后肥胖症和2型糖尿病改善效果的影响
柯志刚1, 童卫东1,()   
  1. 1. 400042 重庆,第三军医大学大坪医院野战外科研究所胃结直肠肛门外科
  • 收稿日期:2016-11-22 出版日期:2016-11-30
  • 通信作者: 童卫东

Influence of the length of bypass intestine on the improvement effect of obesity and type 2 diabetes mellitus after gastric bypass

Zhigang Ke1, Weidong Tong1()   

  • Received:2016-11-22 Published:2016-11-30
  • Corresponding author: Weidong Tong
引用本文:

柯志刚, 童卫东. 小肠旷置长度对胃旁路术后肥胖症和2型糖尿病改善效果的影响[J]. 中华肥胖与代谢病电子杂志, 2016, 02(04): 237-240.

Zhigang Ke, Weidong Tong. Influence of the length of bypass intestine on the improvement effect of obesity and type 2 diabetes mellitus after gastric bypass[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2016, 02(04): 237-240.

[1]
Pories WJ, Swanson MS, MacDonald KG, et al: Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus[J]. Ann Surg, 1995, 222(3):339-352.
[2]
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes[J]. N Engl J Med, 2012, 366(17):1567-1576.
[3]
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes[J]. N Engl J Med, 2014, 370(21):2002-2013.
[4]
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes[J]. N Engl J Med, 2012, 366(17):1577-1585.
[5]
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial[J]. Lancet, 2015, 386(9997):964-973.
[6]
Buchwald H, Consensus Conference Panel. Consensus conference statement bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers[J]. Surg Obes Relat Dis, 2005, 1(3):371-381.
[7]
Anderwald CH, Tura A, Promintzer-Schifferl M, et al. Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgery[J]. Diabetes care, 2012, 35(12):2580-2587.
[8]
Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures[J]. Jama, 2005, 294(15):1909-1917.
[9]
Perugini RA, Malkani S. Remission of type 2 diabetes mellitus following bariatric surgery: review of mechanisms and presentation of the concept of 'reversibility'[J]. Curr Opin Endocrinol Diabetes Obes, 2011, 18(2):119-128.
[10]
Laferrère B. Effect of gastric bypass surgery on the incretins[J]. Diabetes Metab, 2009, 35(6 Pt 2):513-517.
[11]
Christou NV, Look D, Maclean LD. Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years[J]. Ann Surg, 2006, 244(5):734-740.
[12]
Torres JC, Oca CF, Garrison RN. Gastric bypass: Roux-en-Y gastrojejunostomy from the lesser curvature[J]. South Med J, 1983, 76(10):1217-1221.
[13]
Bruder SJ, Freeman JB, Brazeau-Gravelle P. Lengthening the Roux-Y Limb increases weight loss after gastric bypass: a preliminary report[J]. Obes Surg, 1991, 1(1):73-77.
[14]
Brolin RE, Kenler HA, Gorman JH, et al. Long-limb gastric bypass in the superobese. A prospective randomized study[J]. Ann Surg, 1992, 215(4):387-395.
[15]
Brolin RE, LaMarca LB, Kenler HA, et al. Malabsorptive gastric bypass in patients with superobesity[J]. J Gastrointest Surg, 2002, 6(2):195-205.
[16]
Freeman JB, Kotlarewsky M, Phoenix C. Weight loss after extended gastric bypass[J]. Obes Surg, 1997, 7(4):337-344.
[17]
Choban PS, Flancbaum L. The effect of Roux limb lengths on outcome after Roux-en-Y gastric bypass: a prospective, randomized clinical trial[J]. Obes Surg, 2002, 12(4):540-545.
[18]
MacLean LD, Rhode BM, Nohr CW. Long- or short-limb gastric bypass?[J] J Gastrointest Surg, 2001, 5(5):525-530.
[19]
Gleysteen JJ. Five-year outcome with gastric bypass: Roux limb length makes a difference[J]. Surg Obes Relat Dis, 2009, 5(2):242-249.
[20]
Feng JJ, Gagner M, Pomp A, et al. Effect of standard vs extended Roux limb length on weight loss outcomes after laparoscopic Roux-en-Y gastric bypass[J]. Surg Endosc, 2003, 17(7):1055-1060.
[21]
Inabnet WB, Quinn T, Gagner M, et al. Laparoscopic Roux-en-Y gastric bypass in patients with BMI<50: a prospective randomized trial comparing short and long limb lengths[J]. Obes Surg, 2005, 15(1):51-57.
[22]
Sarhan M, Choi JJ, Al Sawwaf M, et al. Is weight loss better sustained with long-limb gastric bypass in the super-obese?[J]. Obesity surgery, 2011, 21(9):1337-1343.
[23]
Valezi AC, Marson AC, Merguizo RA, et al. Roux-en-Y gastric bypass: limb length and weight loss[J]. Arq Bras Ci Dig, 2014, 27(Suppl 1):56-58.
[24]
Lee S, Sahagian KG, Schriver JP. Relationship between varying Roux limb lengths and weight loss in gastric bypass[J]. Curr Surg, 2006, 63(4):259-263.
[25]
Scopinaro N, Gianetta E, Civalleri D, et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man[J]. Br J Surg, 1979, 66(9):618-620.
[26]
Sugerman HJ, Kellum JM, DeMaria EJ. Conversion of proximal to distal gastric bypass for failed gastric bypass for superobesity[J]. J Gastrointest Surg, 1997, 1(6):517-526.
[27]
Brolin RE, Cody RP. Adding malabsorption for weight loss failure after gastric bypass[J]. Surg Endosc, 2007, 21(11):1924-1926.
[28]
Nelson WK, Fatima J, Houghton SG, et al. The malabsorptive very, very long limb Roux-en-Y gastric bypass for super obesity: results in 257 patients[J]. Surgery, 2006, 140(4):517-523.
[29]
McConnell DB, O'rourke RW, Deveney CW. Common channel length predicts outcomes of biliopancreatic diversion alone and with the duodenal switch surgery[J]. Am J Surg, 2005, 189(5):536-540.
[30]
Stefanidis D, Kuwada TS, Gersin KS. The importance of the length of the limbs for gastric bypass patients--an evidence-based review[J]. Obes Surg, 2011, 21(1):119-124.
[31]
Savassi-Rocha AL, Diniz MT, Savassi-Rocha PR, et al. Influence of jejunoileal and common limb length on weight loss following Roux-en-Y gastric bypass[J]. Obes Surg, 2008, 18(11):1364-1368.
[32]
Abellan I, Luján J, Frutos MD, et al. The influence of the percentage of the common limb in weight loss and nutritional alterations after laparoscopic gastric bypass[J]. Surg Obes Relat Dis, 2014, 10(5):829-833.
[33]
Navez J, Dardamanis D, Thissen JP, et al. Laparoscopic Roux-en-Y gastric bypass for morbid obesity: comparison of primary versus revisional bypass by using the BAROS score[J]. Obes Surg, 2015, 25(5):812-817.
[34]
Hernández-Martínez J, Calvo-Ros MÁ. Gastric bypass with fixed 230-cm-long common limb and variable alimentary and biliopancreatic limbs in morbid obesity[J]. Obes Surg, 2011, 21(12):1879-1886.
[35]
Pinheiro JS, Schiavon CA, Pereira PB, et al. Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients[J]. Surg Obes Relat Dis, 2008, 4(4):521-527.
[36]
Kaska L, Kobiela J, Proczko M, et al. Does the length of the biliary limb influence medium-term laboratory remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass in morbidly obese patients?[J] Wideochir Inne Tech Maloinwazyjne, 2014, 9(1):31-39.
[37]
Müller MK, Räder S, Wildi S, et al. Long-term follow-up of proximal versus distal laparoscopic gastric bypass for morbid obesity[J]. Br J Surg, 2008, 95(11):1375-1379.
[1] 王颉, 周游. 二甲双胍治疗骨关节炎的机制及其研究进展[J]. 中华关节外科杂志(电子版), 2024, 18(03): 372-378.
[2] 刘正宇, 刘春风, 王振. 改良后外侧入路半髋置换治疗股骨颈骨折的早期疗效[J]. 中华关节外科杂志(电子版), 2024, 18(03): 409-413.
[3] 刘昌盛, 江思, 童娟. 可视化超声引导下针刀治疗狭窄性腱鞘炎的疗效分析[J]. 中华关节外科杂志(电子版), 2024, 18(02): 160-166.
[4] 王卉, 薛宝睿, 李恭驰, 刘慧真, 雷霞, 李炳辉. 2型糖尿病患者下肢动脉硬化的影响因素分析[J]. 中华损伤与修复杂志(电子版), 2024, 19(02): 147-152.
[5] 陈嘉婷, 杜美君, 石冰, 黄汉尧. 母体系统性疾病对新生儿唇腭裂发生的影响[J]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 262-268.
[6] 朴成林, 蓝炘, 司振铎, 李强, 冯健, 安峰铎, 冷建军. 胰十二指肠切除联合肝切除术疗效分析:附5例报告(附视频)[J]. 中华普通外科学文献(电子版), 2024, 18(05): 363-367.
[7] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[8] 吉顺富, 汤晓燕, 徐进. 腹腔镜近端胃癌根治术中拓展胃后间隙在肥胖患者中的应用研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 393-396.
[9] 杨波, 胡旭, 何金艳, 谢铭. 腹腔镜袖状胃切除术管胃固定研究现状[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 452-455.
[10] 刘盾, 潘晟. 不同入路腹腔镜袖状胃切除术用于肥胖症合并2型糖尿病的效果[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 150-154.
[11] 颜帅, 胡旭, 苟晓梅, 谢铭. 腹腔镜胃袖状切除术后并发症处置策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 220-224.
[12] 崔磊, 徐东升. 减重手术治疗肥胖患者胰岛素抵抗的研究进展[J]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 127-132.
[13] 邢颖, 闫文貌. 单孔腹腔镜袖状胃切除术发展现状[J]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 133-137.
[14] 颜宥彤, 赵锐, 万谦益, 张贵祥, 沈弘毅, 程中, 陈亿. GLP-1受体激动剂——司美格鲁肽的应用及安全性[J]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 88-93.
[15] 中国医师协会外科医师分会肥胖和糖尿病外科专家工作组. 减重手术相关贫血管理策略中国专家共识(2024版)[J]. 中华肥胖与代谢病电子杂志, 2024, 10(01): 1-8.
阅读次数
全文


摘要